Massar Omar

8PUBLICATIONS
17CO-AUTHORS
Epidemiological modellingNutritional epidemiologyRespiratory diseasesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 19, 2026
Effects of empagliflozin on right ventricular free-wall strain in patients with heart failure and reduced ejection fraction: results from the Empire HF Trial.

Massar Omar, Jesper Jensen, Mulham Ali

|Jan 08, 2026
Effects of empagliflozin in patients at risk of heart failure: the Empire Prevent Metabolic Trial.

Camilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar

|Jun 12, 2025
Effects of Empagliflozin on Right Ventricular Function in Heart Failure with Reduced Ejection Fraction.

Massar Omar, Jesper Jensen, Peter H Frederiksen

|Aug 03, 2023
Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial.

Barry A Borlaug, Yogesh N V Reddy, Amanda Braun

|Jul 07, 2022
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.

Kazunori Omote, Hidemi Sorimachi, Masaru Obokata

|Nov 08, 2021
Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial.

Massar Omar, Jesper Jensen, Daniel Burkhoff

Pageof 2

Frequent Collaborators

4 joint publications

Caroline Kistorp

4 joint publications

Finn Gustafsson

4 joint publications

Barry A Borlaug

4 joint publications

Lars Køber